BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Enomoto H, Nishiguchi S. Factors associated with the response to interferon-based antiviral therapies for chronic hepatitis C. World J Hepatol 2015; 7(26): 2681-2687 [PMID: 26609345 DOI: 10.4254/wjh.v7.i26.2681]
URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2681.htm
Number Citing Articles
1
Beatriz Suarez, Laura Prats-Mari, Juan P. Unfried, Puri Fortes. LncRNAs in the Type I Interferon Antiviral ResponseInternational Journal of Molecular Sciences 2020; 21(17): 6447 doi: 10.3390/ijms21176447
2
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C virusesWorld Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
3
Hany S. Bedair, Brian M. Schurko, Maureen K. Dwyer, David Novikov, Afshin A. Anoushiravani, Ran Schwarzkopf. Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint InfectionThe Journal of Arthroplasty 2019; 34(1): 132 doi: 10.1016/j.arth.2018.09.036
4
Thomas Blank, Marco Prinz. Type I interferon pathway in CNS homeostasis and neurological disordersGlia 2017; 65(9): 1397 doi: 10.1002/glia.23154
5
Camelia Sultana, Gabriela Oprişan, Monica Delia Teleman, Sorin Dinu, Cristiana Oprea, Mihai Voiculescu, Simona Ruta. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis CWorld Journal of Gastroenterology 2016; 22(37): 8406-8413 doi: 10.3748/wjg.v22.i37.8406
6
Armstrong Murira, Alain Lamarre. Type-I Interferon Responses: From Friend to Foe in the Battle against Chronic Viral InfectionFrontiers in Immunology 2016; 7 doi: 10.3389/fimmu.2016.00609
7
Adrian Keogh, Sevil Şenkardeş, Jeffrey Idle, Ş. Küçükgüzel, Diren Beyoğlu. A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B CellsMetabolites 2017; 7(2): 23 doi: 10.3390/metabo7020023
8
Jun Inoue, Atsushi Kanno, Yuta Wakui, Masahito Miura, Tomoo Kobayashi, Tatsuki Morosawa, Takayuki Kogure, Eiji Kakazu, Masashi Ninomiya, Yasuyuki Fujisaka, Teruyuki Umetsu, Satoshi Takai, Takuya Nakamura, Tooru Shimosegawa. Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir TreatmentThe Tohoku Journal of Experimental Medicine 2017; 241(1): 21 doi: 10.1620/tjem.241.21
9
Jae-Won Lee, Won Kim, Eun-Kyung Kwon, Yuri Kim, Hyun Mu Shin, Dong-Hyun Kim, Chan-Ki Min, Ji-Yeob Choi, Won-Woo Lee, Myung-Sik Choi, Byeong Gwan Kim, Nam-Hyuk Cho, Eui-Cheol Shin. Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis CPLOS ONE 2017; 12(6): e0179094 doi: 10.1371/journal.pone.0179094